Literature DB >> 239166

The absorption and elimination of orally administered (14C)hyoscine N-butylbromide (butylscopolamine).

H Vapaatalo, A Penttilä, E Kaltiala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 239166     DOI： 10.1111/j.2042-7158.1975.tb09503.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  1 in total

1.  The BUSCOPAN study: a randomized-controlled non-inferiority trial of a continuous butylscopolamine infusion versus placebo in patients with a renal colic not responding to oral non-steroidal anti-inflammatory drugs.

Authors:  S Weltings; K T Buddingh; D C van Diepen; R C M Pelger; H Putter; M Rad; B M A Schout; H Roshani
Journal:  World J Urol       Date:  2020-09-19       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.